V12 SENTINEL ENGINE · AI MARKET ANALYSIS
Mid
M
MEDAI Stock Diagnostic Report

Medifast targets return to profitability in Q4 2026 as Trilivy rollout continues

[GROQ] Medifast aims to restore profitability in the fourth quarter of 2026, with continued expectations for revenue growth from the launch of Trilivy.

View Source Article ↗
AI CATALYST SCORE80 / 100Score computed by Sentinel V12
REFERENCE PRICE$9.74Reference entry price at analysis time
+
ANALYSIS HISTORY

MED Analysis History (Last 30 Days)

Diagnosed AtTickerAI ScoreTier
2026-08-21 17:17:55MED65MidView Report →
2026-08-04 15:27:47MED90S-ClassView Report →
2026-08-04 04:27:33MED80MidView Report →
View Full History for MED (Blueprint) →